---
figid: PMC10159521__10.1177_15353702231151962-fig9
figtitle: miR-613 suppresses renal cell carcinoma proliferation, invasion and migration
  by regulating the AXL/AKT pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10159521
filename: 10.1177_15353702231151962-fig9.jpg
figlink: /pmc/articles/PMC10159521/figure/fig9-15353702231151962/
number: F9
caption: The miR-613/AXL/PI3K/AKT regulation axis in RCC progression is depicted schematically.
  AXL overexpression was found to activate the PI3K/AKT signaling pathway, promoting
  RCC progression. Furthermore, miR-613 can bind to the AXL 3’-UTR and inhibit AXL
  expression, preventing AXL-mediated PI3K/AKT signaling activation.
papertitle: miR-613 suppresses renal cell carcinoma proliferation, invasion and migration
  by regulating the AXL/AKT pathway.
reftext: Wanli Duan, et al. Exp Biol Med (Maywood). 2023 Feb;248(4):281-292.
year: '2023'
doi: 10.1177/15353702231151962
journal_title: Experimental Biology and Medicine
journal_nlm_ta: Exp Biol Med (Maywood)
publisher_name: SAGE Publications
keywords: RCC | miR-613 | AXL | AKT | proliferation | invasion | migration
automl_pathway: 0.9546295
figid_alias: PMC10159521__F9
figtype: Figure
redirect_from: /figures/PMC10159521__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10159521__10.1177_15353702231151962-fig9.html
  '@type': Dataset
  description: The miR-613/AXL/PI3K/AKT regulation axis in RCC progression is depicted
    schematically. AXL overexpression was found to activate the PI3K/AKT signaling
    pathway, promoting RCC progression. Furthermore, miR-613 can bind to the AXL 3’-UTR
    and inhibit AXL expression, preventing AXL-mediated PI3K/AKT signaling activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MIR613
  - GAS6
  - AXL
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
---
